Selected research
Market Analysis & Forecast
Global Cobamamide Drugs Market Analysis and Forecast 2026-2032
Market perspective
The global Cobamamide Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cobamamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cobamamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cobamamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cobamamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Cobamamide Drugs include Chongqing Yaoyou Pharmaceutical, Jiuquan Dadeli pharmaceutical, Jiangsu Jiuxu Pharmaceutical, North China Pharmaceutical Group, Hebei Zhitong Biopharmaceutical, Hainan Star Pharmaceutical, Haerbin Medisan and Sinopharm Group Rongsheng Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Cobamamide Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cobamamide Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Cobamamide Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cobamamide Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cobamamide Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cobamamide Drugs sales, projected growth trends, production technology, application and end-user industry.
Cobamamide Drugs Segment by Company
Chongqing Yaoyou Pharmaceutical
Jiuquan Dadeli pharmaceutical
Jiangsu Jiuxu Pharmaceutical
North China Pharmaceutical Group
Hebei Zhitong Biopharmaceutical
Hainan Star Pharmaceutical
Haerbin Medisan
Sinopharm Group Rongsheng Pharmaceutical
Cobamamide Drugs Segment by Type
Injection
Tablets
Cobamamide Drugs Segment by Application
Hospital
Drug Store
Other
Cobamamide Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cobamamide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cobamamide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cobamamide Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Cobamamide Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Cobamamide Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cobamamide Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablets
Applications
- Hospital
- Drug Store
- Other
Companies covered
- Chongqing Yaoyou Pharmaceutical
- Jiuquan Dadeli pharmaceutical
- Jiangsu Jiuxu Pharmaceutical
- North China Pharmaceutical Group
- Hebei Zhitong Biopharmaceutical
- Hainan Star Pharmaceutical
- Haerbin Medisan
- Sinopharm Group Rongsheng Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cobamamide Drugs Market by Type
- 1.2.1 Global Cobamamide Drugs Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Injection
- 1.2.3 Tablets
- 1.3 Cobamamide Drugs Market by Application
- 1.3.1 Global Cobamamide Drugs Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Drug Store
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cobamamide Drugs Market Dynamics
- 2.1 Cobamamide Drugs Industry Trends
- 2.2 Cobamamide Drugs Industry Drivers
- 2.3 Cobamamide Drugs Industry Opportunities and Challenges
- 2.4 Cobamamide Drugs Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Cobamamide Drugs Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Cobamamide Drugs Revenue by Region
- 3.2.1 Global Cobamamide Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cobamamide Drugs Revenue by Region (2021-2026)
- 3.2.3 Global Cobamamide Drugs Revenue by Region (2027-2032)
- 3.2.4 Global Cobamamide Drugs Revenue Market Share by Region (2021-2032)
- 3.3 Global Cobamamide Drugs Sales Estimates and Forecasts 2021-2032
- 3.4 Global Cobamamide Drugs Sales by Region
- 3.4.1 Global Cobamamide Drugs Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Cobamamide Drugs Sales by Region (2021-2026)
- 3.4.3 Global Cobamamide Drugs Sales by Region (2027-2032)
- 3.4.4 Global Cobamamide Drugs Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Cobamamide Drugs Revenue by Manufacturers
- 4.1.1 Global Cobamamide Drugs Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Cobamamide Drugs Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Cobamamide Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cobamamide Drugs Sales by Manufacturers
- 4.2.1 Global Cobamamide Drugs Sales by Manufacturers (2021-2026)
- 4.2.2 Global Cobamamide Drugs Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Cobamamide Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Cobamamide Drugs Sales Price by Manufacturers (2021-2026)
- 4.4 Global Cobamamide Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Cobamamide Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Cobamamide Drugs Manufacturers, Product Type & Application
- 4.7 Global Cobamamide Drugs Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Cobamamide Drugs Market CR5 and HHI
- 4.8.2 2025 Cobamamide Drugs Tier 1, Tier 2, and Tier 3
5 Cobamamide Drugs Market by Type
- 5.1 Global Cobamamide Drugs Revenue by Type
- 5.1.1 Global Cobamamide Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Cobamamide Drugs Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Cobamamide Drugs Revenue Market Share by Type (2021-2032)
- 5.2 Global Cobamamide Drugs Sales by Type
- 5.2.1 Global Cobamamide Drugs Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Cobamamide Drugs Sales by Type (2021-2032) & (Kg)
- 5.2.3 Global Cobamamide Drugs Sales Market Share by Type (2021-2032)
- 5.3 Global Cobamamide Drugs Price by Type
6 Cobamamide Drugs Market by Application
- 6.1 Global Cobamamide Drugs Revenue by Application
- 6.1.1 Global Cobamamide Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Cobamamide Drugs Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Cobamamide Drugs Revenue Market Share by Application (2021-2032)
- 6.2 Global Cobamamide Drugs Sales by Application
- 6.2.1 Global Cobamamide Drugs Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Cobamamide Drugs Sales by Application (2021-2032) & (Kg)
- 6.2.3 Global Cobamamide Drugs Sales Market Share by Application (2021-2032)
- 6.3 Global Cobamamide Drugs Price by Application
7 Company Profiles
- 7.1 Chongqing Yaoyou Pharmaceutical
- 7.1.1 Chongqing Yaoyou Pharmaceutical Company Information
- 7.1.2 Chongqing Yaoyou Pharmaceutical Business Overview
- 7.1.3 Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Product Portfolio
- 7.1.5 Chongqing Yaoyou Pharmaceutical Recent Developments
- 7.2 Jiuquan Dadeli pharmaceutical
- 7.2.1 Jiuquan Dadeli pharmaceutical Company Information
- 7.2.2 Jiuquan Dadeli pharmaceutical Business Overview
- 7.2.3 Jiuquan Dadeli pharmaceutical Cobamamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Jiuquan Dadeli pharmaceutical Cobamamide Drugs Product Portfolio
- 7.2.5 Jiuquan Dadeli pharmaceutical Recent Developments
- 7.3 Jiangsu Jiuxu Pharmaceutical
- 7.3.1 Jiangsu Jiuxu Pharmaceutical Company Information
- 7.3.2 Jiangsu Jiuxu Pharmaceutical Business Overview
- 7.3.3 Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Product Portfolio
- 7.3.5 Jiangsu Jiuxu Pharmaceutical Recent Developments
- 7.4 North China Pharmaceutical Group
- 7.4.1 North China Pharmaceutical Group Company Information
- 7.4.2 North China Pharmaceutical Group Business Overview
- 7.4.3 North China Pharmaceutical Group Cobamamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 North China Pharmaceutical Group Cobamamide Drugs Product Portfolio
- 7.4.5 North China Pharmaceutical Group Recent Developments
- 7.5 Hebei Zhitong Biopharmaceutical
- 7.5.1 Hebei Zhitong Biopharmaceutical Company Information
- 7.5.2 Hebei Zhitong Biopharmaceutical Business Overview
- 7.5.3 Hebei Zhitong Biopharmaceutical Cobamamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Hebei Zhitong Biopharmaceutical Cobamamide Drugs Product Portfolio
- 7.5.5 Hebei Zhitong Biopharmaceutical Recent Developments
- 7.6 Hainan Star Pharmaceutical
- 7.6.1 Hainan Star Pharmaceutical Company Information
- 7.6.2 Hainan Star Pharmaceutical Business Overview
- 7.6.3 Hainan Star Pharmaceutical Cobamamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Hainan Star Pharmaceutical Cobamamide Drugs Product Portfolio
- 7.6.5 Hainan Star Pharmaceutical Recent Developments
- 7.7 Haerbin Medisan
- 7.7.1 Haerbin Medisan Company Information
- 7.7.2 Haerbin Medisan Business Overview
- 7.7.3 Haerbin Medisan Cobamamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Haerbin Medisan Cobamamide Drugs Product Portfolio
- 7.7.5 Haerbin Medisan Recent Developments
- 7.8 Sinopharm Group Rongsheng Pharmaceutical
- 7.8.1 Sinopharm Group Rongsheng Pharmaceutical Company Information
- 7.8.2 Sinopharm Group Rongsheng Pharmaceutical Business Overview
- 7.8.3 Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Product Portfolio
- 7.8.5 Sinopharm Group Rongsheng Pharmaceutical Recent Developments
8 North America
- 8.1 North America Cobamamide Drugs Market Size by Type
- 8.1.1 North America Cobamamide Drugs Revenue by Type (2021-2032)
- 8.1.2 North America Cobamamide Drugs Sales by Type (2021-2032)
- 8.1.3 North America Cobamamide Drugs Price by Type (2021-2032)
- 8.2 North America Cobamamide Drugs Market Size by Application
- 8.2.1 North America Cobamamide Drugs Revenue by Application (2021-2032)
- 8.2.2 North America Cobamamide Drugs Sales by Application (2021-2032)
- 8.2.3 North America Cobamamide Drugs Price by Application (2021-2032)
- 8.3 North America Cobamamide Drugs Market Size by Country
- 8.3.1 North America Cobamamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Cobamamide Drugs Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Cobamamide Drugs Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Cobamamide Drugs Market Size by Type
- 9.1.1 Europe Cobamamide Drugs Revenue by Type (2021-2032)
- 9.1.2 Europe Cobamamide Drugs Sales by Type (2021-2032)
- 9.1.3 Europe Cobamamide Drugs Price by Type (2021-2032)
- 9.2 Europe Cobamamide Drugs Market Size by Application
- 9.2.1 Europe Cobamamide Drugs Revenue by Application (2021-2032)
- 9.2.2 Europe Cobamamide Drugs Sales by Application (2021-2032)
- 9.2.3 Europe Cobamamide Drugs Price by Application (2021-2032)
- 9.3 Europe Cobamamide Drugs Market Size by Country
- 9.3.1 Europe Cobamamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Cobamamide Drugs Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Cobamamide Drugs Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Cobamamide Drugs Market Size by Type
- 10.1.1 China Cobamamide Drugs Revenue by Type (2021-2032)
- 10.1.2 China Cobamamide Drugs Sales by Type (2021-2032)
- 10.1.3 China Cobamamide Drugs Price by Type (2021-2032)
- 10.2 China Cobamamide Drugs Market Size by Application
- 10.2.1 China Cobamamide Drugs Revenue by Application (2021-2032)
- 10.2.2 China Cobamamide Drugs Sales by Application (2021-2032)
- 10.2.3 China Cobamamide Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cobamamide Drugs Market Size by Type
- 11.1.1 Asia Cobamamide Drugs Revenue by Type (2021-2032)
- 11.1.2 Asia Cobamamide Drugs Sales by Type (2021-2032)
- 11.1.3 Asia Cobamamide Drugs Price by Type (2021-2032)
- 11.2 Asia Cobamamide Drugs Market Size by Application
- 11.2.1 Asia Cobamamide Drugs Revenue by Application (2021-2032)
- 11.2.2 Asia Cobamamide Drugs Sales by Application (2021-2032)
- 11.2.3 Asia Cobamamide Drugs Price by Application (2021-2032)
- 11.3 Asia Cobamamide Drugs Market Size by Country
- 11.3.1 Asia Cobamamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Cobamamide Drugs Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Cobamamide Drugs Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cobamamide Drugs Market Size by Type
- 12.1.1 SAMEA Cobamamide Drugs Revenue by Type (2021-2032)
- 12.1.2 SAMEA Cobamamide Drugs Sales by Type (2021-2032)
- 12.1.3 SAMEA Cobamamide Drugs Price by Type (2021-2032)
- 12.2 SAMEA Cobamamide Drugs Market Size by Application
- 12.2.1 SAMEA Cobamamide Drugs Revenue by Application (2021-2032)
- 12.2.2 SAMEA Cobamamide Drugs Sales by Application (2021-2032)
- 12.2.3 SAMEA Cobamamide Drugs Price by Application (2021-2032)
- 12.3 SAMEA Cobamamide Drugs Market Size by Country
- 12.3.1 SAMEA Cobamamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Cobamamide Drugs Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Cobamamide Drugs Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Cobamamide Drugs Value Chain Analysis
- 13.1.1 Cobamamide Drugs Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Cobamamide Drugs Production Mode & Process
- 13.2 Cobamamide Drugs Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Cobamamide Drugs Distributors
- 13.2.3 Cobamamide Drugs Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst